The Department of Health (LDH) issued several bulletins:
- Louisiana Medicaid Pharmacy Single Preferred Drug List (PDL) Update – Effective July 1, 2024
- Louisiana Medicaid Pharmacy Point of Sale Edits for Vonoprazan (Voquezna®), Sitagliptin (Zituvio™), and Budesonide (Eohilia™) – Effective July 1, 2024
- Louisiana Medicaid Pharmacy Point of Sale Clinical Authorization and Updates – Effective July 1, 2024
- Louisiana Medicaid Pharmacy Point of Sale Quantity Limit – Effective July 1, 2024
- Louisiana Medicaid Pharmacy Point of Sale Diagnosis Code Requirement – Effective July 1, 2024
Also in Louisiana, three PBM reform bills pharmacies supported were sent to Gov. Jeff Landy (R) to be signed into law. SB 444 prohibits reimbursement below cost, HB 603 adds guardrails for PBM audits and SB 281 enhances the Attorney General’s enforcement authority over audits.
Finally in Louisiana, LHD created an on-line form allowing anyone to request a Medicaid Policy change.
For more information, contact NACDS’ Mary Staples at 817-442-1155.